Mark Baldry
CIK 1644137 · Chief Commercial Officer · last filed 2025-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$330.3K
Companies
3
Total Filings
11
Lifetime Open-Market Net
-$5.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XFOR | Chief Commercial Officer | 25,337 | $4.00 | $101.3K | -$5.4K | 9 | 2025-06-03 |
| WVE | Chief Commerical Officer | 39,000 | $5.87 | $228.9K | $0 | 1 | 2019-08-07 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | VP Global Marketing | 25,000 | $14.49 | $362.2K | $0 | 1 | 2015-06-04 |
Recent Filings · Page 2 of 2
11 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-06-04 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
Showing 11–11 of 11
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.